JD Supra

Express Scripts Adds Biosimilar SEMGLEE to Preferred Formulary

In October, Express Scripts announced that it would add Viatris’ SEMGLEE (insulin glargine-yfgn) injection as a preferred therapy on its formulary beginning in January 2022. Back in July, the FDA ...
FierceHealthcare

Express Scripts to add Humira biosimilars to formulary as preferred products

Express Scripts said it will continue to evaluate biosimilars for Humira as they are approved and expects adding these products to its formulary will pay off in significant savings. (Express Scripts) ...
Yahoo Finance

INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Business Insider

Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients

Express Scripts will include Cyltezo and both Sandoz products (Hyrimoz and unbranded adalimumab-adaz) – inflammatory disease biosimilars with competitive net costs – as preferred products on the ...
The Financial

Amgen Announces Repatha Co-Preferred Position on Express Scripts National Formulary

The FINANCIAL — Amgen on October 6 announced that Express Scripts will provide access to Repatha (evolocumab) through its national formulary. “Ensuring access to Repatha for appropriate patients is ...
FierceHealthcare

Express Scripts puts insulin biosimilar Semglee on preferred formulary

Express Scripts will prefer the first Food and Drug Administration-approved interchangeable biosimilar product, a move it says will lead to millions in savings. Semglee, which was developed by Viatris ...